(Q39814750)

14 September 2017

1 reference

title

Flecainide. A preliminary review of its pharmacodynamic properties and therapeutic efficacy (English)

1 reference

14 September 2017

1 reference

B Holmes

1

1 reference

PubMed ID

3882390

14 September 2017

R C Heel

series ordinal

2

1 reference

14 September 2017

1 January 1985

1 reference

14 September 2017

1 reference

14 September 2017

29

1 reference

14 September 2017

1

1 reference

14 September 2017

1-33

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-198529010-00001

14 September 2017

0 references

cites work

Hemodynamic effects of a new antiarrhythmic agent, flecainide (R-818), in coronary heart disease.

1 reference

12 December 2020

[Effect of flecainide on chronic ventricular arrhythmias (author's transl)]

1 reference

12 December 2020

[Formation of a bundle branch block with flecainide]

1 reference

12 December 2020

Antiarrhythmic and Hemodynamic Actions of Flecainide Acetate (R-818) in the Ischemic Porcine Heart

1 reference

12 December 2020

Long-term tocainide therapy for ventricular arrhythmias

1 reference

12 December 2020

A comparison of the antiarrhythmic effects on AV junctional re-entrant tachycardia of oral and intravenous flecainide acetate

1 reference

12 December 2020

Flecainide: one-year efficacy in patients with chronic ventricular arrhythmias

1 reference

12 December 2020

Flecainide versus quinidine for treatment of chronic ventricular arrhythmias. A multicenter clinical trial

1 reference

12 December 2020

Cardiac electrophysiologic effects of flecainide acetate for paroxysmal reentrant junctional tachycardias

1 reference

12 December 2020

Limitations of routine long-term electrocardiographic monitoring to assess ventricular ectopic frequency

1 reference

12 December 2020

Effect of the Antiarrhythmic Agent Flecainide Acetate on Acute and Chronic Pacing Thresholds

1 reference

12 December 2020

Effect of Flecainide on Action Potentials and Alternating Current-Induced Arrhythmias in Mammalian Myocardium

1 reference

12 December 2020

Clinical electrophysiologic study of antiarrhythmic properties of flecainide: acute intraventricular delayed conduction and prolonged repolarization in regular paced and premature beats using intracardiac monophasic action potentials with programmed

1 reference

12 December 2020

Antiarrhythmic effects of flecainide

1 reference

12 December 2020

Relationship between plasma concentrations and suppression of ventricular extrasystoles by flecainide acetate (R-818), a new antiarrhythmic, in patients

1 reference

12 December 2020

Ventricular tachycardia associated with flecainide

1 reference

12 December 2020

Flecainide-induced QT prolongation and ventricular tachycardia

1 reference

12 December 2020

Aggravation and provocation of ventricular arrhythmias by antiarrhythmic drugs

1 reference

12 December 2020

Electrophysiological Effects of a New Antiarrhythmic Agent, Flecainide, on the Intact Canine Heart

1 reference

12 December 2020

Interaction of flecainide with digoxin and propranolol

1 reference

12 December 2020

Extracardiac adverse effects of flecainide

1 reference

12 December 2020

Acute electrophysiological effects of flecainide acetate on cardiac conduction and refractoriness in man

1 reference

12 December 2020

Electrophysiologic effects of flecainide acetate in patients with sinus nodal dysfunction

1 reference

12 December 2020

Electrophysiologic and antiarrhythmic effects of oral flecainide in patients with inducible ventricular tachycardia

1 reference

12 December 2020

Study of flecainide in the treatment of ventricular arrhythmia

1 reference

12 December 2020

Electrophysiologic effects of flecainide acetate on sinus node function, anomalous atrioventricular connections, and pacemaker thresholds

1 reference

12 December 2020

Electrophysiological effects of flecainide on stimulus-inducible ventricular tachycardia

1 reference

12 December 2020

Use of flecainide acetate in the treatment of premature ventricular contractions

1 reference

12 December 2020

Suppression of resistant ventricular arrhythmias by twice daily dosing with flecainide.

1 reference

12 December 2020

Electrophysiologic properties of flecainide acetate

1 reference

12 December 2020

The haemodynamic effect of intravenous flecainide acetate in patients with coronary artery disease

1 reference

12 December 2020

Metabolism of flecainide

1 reference

12 December 2020

Oral digoxin pharmacokinetics during multiple-dose flecainide treatment

1 reference

12 December 2020

Effects of flecainide on contractile force and electrophysiological parameters in cardiac muscle

1 reference

12 December 2020

Evaluation of flecainide acetate in the management of patients at high risk of sudden cardiac death

1 reference

12 December 2020

Effects of flecainide on ventricular function: clinical and experimental correlations.

1 reference

12 December 2020

Class 1 antiarrhythmic drugs--characteristic electrocardiographic differences when assessed by atrial and ventricular pacing

1 reference

12 December 2020

Long-term antiarrhythmic therapy with flecainide

1 reference

12 December 2020

A double-blind, crossover comparison of flecainide acetate and disopyramide phosphate in the treatment of ventricular premature complexes

1 reference

12 December 2020

Oral flecainide acetate for the treatment of ventricular arrhythmias

1 reference

12 December 2020

[Antiarrhythmic efficacy of mexiletine, propafenone and flecainide in ventricular premature beats. A comparative study in patients after myocardial infarction (author's transl)]

1 reference

12 December 2020

Suppression of complex ventricular arrhythmias by oral flecainide

1 reference

12 December 2020

Oral flecainide for suppression of ventricular arrhythmias

1 reference

12 December 2020

Malignant ventricular tachyarrhythmias associated with the use of encainide

1 reference

12 December 2020

Electrophysiological effects of the new antiarrhythmic drug flecainide (R 818) in man (author's transl)

1 reference

12 December 2020

Biotransformation and elimination of 14C-flecainide acetate in humans

1 reference

12 December 2020

Suppression of ventricular ectopic depolarizations by flecainide acetate, a new antiarrhythmic agent

1 reference

12 December 2020

The influence of urinary pH on flecainide excretion and its serum pharmacokinetics

1 reference

12 December 2020

Proarrhythmic effects of the new antiarrhythmic agent flecainide acetate

1 reference

12 December 2020

1 reference

12 December 2020

Clinical and electrophysiologic assessment of oral flecainide acetate for recurrent ventricular tachycardia: evidence for exacerbation of electrical instability

1 reference

12 December 2020

Flecainide: its proarrhythmic effect and expected changes on the surface electrocardiogram

1 reference

12 December 2020

Antiarrhythmic and electrophysiologic actions of flecainide in animal models.

1 reference

12 December 2020

Subgroups of class 1 antiarrhythmic drugs

1 reference

12 December 2020

10.2165/00003495-198529010-00001

Identifiers

DOI

1 reference

PubMed ID

3882390

Dimensions Publication ID

14 September 2017

0 references

1 reference

PubMed ID

3882390